Isavuconazole in Hematological Patients: Results of a Real-Life Multicentre Observational Seifem Study
{{output}}
Invasive fungal diseases (IFDs) remain a major clinical issue in patients with hematological malignancies (HMs). To confirm the efficacy and safety of the new azole isavuconazole (ISV) in a clinical care setting, we planned a multicenter retrospective study; w... ...
